vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
VIRTUS INVESTMENT PARTNERS, INC. is the larger business by last-quarter revenue ($199.5M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 3.6% vs -82.0%, a 85.5% gap on every dollar of revenue. On growth, VIRTUS INVESTMENT PARTNERS, INC. posted the faster year-over-year revenue change (-4.1% vs -22.7%). Over the past eight quarters, VIRTUS INVESTMENT PARTNERS, INC.'s revenue compounded faster (-5.7% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
PTCT vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $199.5M |
| Net Profit | $-135.0M | $7.1M |
| Gross Margin | — | — |
| Operating Margin | -43.3% | 7.7% |
| Net Margin | -82.0% | 3.6% |
| Revenue YoY | -22.7% | -4.1% |
| Net Profit YoY | -104.8% | -78.1% |
| EPS (diluted) | $-1.63 | $1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $199.5M | ||
| Q4 25 | $164.7M | $208.0M | ||
| Q3 25 | $211.0M | $216.4M | ||
| Q2 25 | $178.9M | $210.5M | ||
| Q1 25 | $1.2B | $217.9M | ||
| Q4 24 | $213.2M | $233.5M | ||
| Q3 24 | $196.8M | $227.0M | ||
| Q2 24 | $186.7M | $224.4M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | $-135.0M | $33.9M | ||
| Q3 25 | $15.9M | $31.3M | ||
| Q2 25 | $-64.8M | $42.7M | ||
| Q1 25 | $866.6M | $28.1M | ||
| Q4 24 | $-65.9M | $39.5M | ||
| Q3 24 | $-106.7M | $49.1M | ||
| Q2 24 | $-99.2M | $26.0M |
| Q1 26 | — | 7.7% | ||
| Q4 25 | -43.3% | 19.1% | ||
| Q3 25 | 1.4% | 21.7% | ||
| Q2 25 | -19.5% | 21.5% | ||
| Q1 25 | 82.5% | 16.8% | ||
| Q4 24 | -76.2% | 21.7% | ||
| Q3 24 | -27.7% | 24.3% | ||
| Q2 24 | -21.5% | 19.7% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | -82.0% | 16.3% | ||
| Q3 25 | 7.5% | 14.5% | ||
| Q2 25 | -36.3% | 20.3% | ||
| Q1 25 | 73.7% | 12.9% | ||
| Q4 24 | -30.9% | 16.9% | ||
| Q3 24 | -54.2% | 21.6% | ||
| Q2 24 | -53.1% | 11.6% |
| Q1 26 | — | $1.05 | ||
| Q4 25 | $-1.63 | $5.15 | ||
| Q3 25 | $0.20 | $4.65 | ||
| Q2 25 | $-0.83 | $6.12 | ||
| Q1 25 | $10.04 | $4.05 | ||
| Q4 24 | $-0.85 | $4.65 | ||
| Q3 24 | $-1.39 | $5.71 | ||
| Q2 24 | $-1.29 | $2.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $136.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $93.6B |
| Total Assets | $2.9B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $136.6M | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
| Q1 26 | — | $93.6B | ||
| Q4 25 | $-205.3M | $934.0M | ||
| Q3 25 | $-155.8M | $918.7M | ||
| Q2 25 | $-206.5M | $896.4M | ||
| Q1 25 | $-185.8M | $893.7M | ||
| Q4 24 | $-1.1B | $897.5M | ||
| Q3 24 | $-1.1B | $889.0M | ||
| Q2 24 | $-980.2M | $868.7M |
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $4.3B | ||
| Q3 25 | $2.6B | $3.9B | ||
| Q2 25 | $2.6B | $3.7B | ||
| Q1 25 | $2.7B | $3.7B | ||
| Q4 24 | $1.7B | $4.0B | ||
| Q3 24 | $1.8B | $3.6B | ||
| Q2 24 | $1.9B | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | — |
| Free Cash FlowOCF − Capex | $-36.6M | — |
| FCF MarginFCF / Revenue | -22.3% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.3M | $-67.2M | ||
| Q3 25 | $-66.3M | $108.3M | ||
| Q2 25 | $-58.3M | $75.8M | ||
| Q1 25 | $870.1M | $-3.8M | ||
| Q4 24 | $-30.0M | $1.8M | ||
| Q3 24 | $-77.0M | $69.1M | ||
| Q2 24 | $-71.5M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-36.6M | $-74.1M | ||
| Q3 25 | $-69.7M | $106.9M | ||
| Q2 25 | $-59.6M | $74.2M | ||
| Q1 25 | $868.4M | $-6.8M | ||
| Q4 24 | $-33.8M | $-3.8M | ||
| Q3 24 | $-77.5M | $68.7M | ||
| Q2 24 | $-78.8M | $68.6M |
| Q1 26 | — | — | ||
| Q4 25 | -22.3% | -35.6% | ||
| Q3 25 | -33.1% | 49.4% | ||
| Q2 25 | -33.3% | 35.2% | ||
| Q1 25 | 73.8% | -3.1% | ||
| Q4 24 | -15.8% | -1.6% | ||
| Q3 24 | -39.4% | 30.3% | ||
| Q2 24 | -42.2% | 30.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 3.3% | ||
| Q3 25 | 1.6% | 0.7% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.1% | 1.4% | ||
| Q4 24 | 1.8% | 2.4% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 4.0% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -1.99× | ||
| Q3 25 | -4.17× | 3.45× | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | 1.00× | -0.13× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |
